1. Synthesis and initial in vitro evaluation of olmutinib derivatives as prospective imaging probe for non-small cell lung cancer

Muammar Fawwaz* , Kenji Mishiro* , Arwansyah Arwansyah, Ryuichi Nishii, Kazuma Ogawa*

Bioimpacts. 2024;14(1): 27774. doi: 10.34172/bi.2023.27774

PMCID: PMC10844591 PMID: 38327635 Scopus ID: 85182753071

Article

PDF

Suppl 1

Full Text

XML

Cited By:

Submit Your Paper Instructions for Authors Aims and Scope Editorial Board Editorial Policies Publication Ethics Policies Editorial Board Policy Abstracting and Indexing Archive

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences.
Acceptance rate (2024): 20%
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar; SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of COPE
Follower of ICMJE
Permission: Creative Commons